Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report)’s stock price reached a new 52-week low during mid-day trading on Tuesday . The company traded as low as C$0.09 and last traded at C$0.10, with a volume of 37646 shares trading hands. The stock had previously closed at C$0.10.
Voyageur Pharmaceuticals Stock Down 5.0%
The firm has a market cap of C$17.05 million, a P/E ratio of -9.50 and a beta of 1.07. The stock’s fifty day moving average is C$0.12 and its two-hundred day moving average is C$0.15. The company has a current ratio of 0.18, a quick ratio of 0.84 and a debt-to-equity ratio of 6.05.
Voyageur Pharmaceuticals Company Profile
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019. Voyageur Pharmaceuticals Ltd. was founded in 2017 and is headquartered in Calgary, Canada.
Featured Articles
- Five stocks we like better than Voyageur Pharmaceuticals
- HIVE Weaponizes Power for an AI Pivot
- A Deep Dive Into NVIDIA’s Latest Portfolio Moves
- Brady Corp Wires Up a Massive AI-Powered Breakout
- Why Home Depot’s Sell-Off Could Become a Huge Opportunity
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
